ArticlemAbs

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans.

Hans Peter Grimm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.